|
|
|
Insider
Information: |
Ra Capital Biotech Fund Lp |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
50,143,338 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$1,000,277,130 |
|
|
Total
Shares |
50,143,338 |
|
|
Total
Value |
$1,000,277,130 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aradigm Corp |
ARDM |
10% Owner |
|
0 |
2007-01-24 |
6,355,000 |
Premium* |
|
Curis Inc |
CRIS |
10% Owner |
|
0 |
2007-08-08 |
7,520,564 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2010-02-03 |
0 |
2010-02-23 |
636,462 |
Premium* |
|
Derma Sciences Inc |
DSCI |
Fmr 10% Owner - See Fn... |
|
0 |
2014-01-10 |
1,694,876 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
Former 10% Owner, See ... |
2013-09-30 |
0 |
2014-09-30 |
6,700,000 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2017-12-18 |
5,074,013 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-22 |
0 |
2016-09-16 |
2,102,169 |
Premium* |
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
|
0 |
2015-11-16 |
7,088,651 |
Premium* |
|
Synthorx, Inc. |
THOR |
10% Owner |
2018-12-11 |
0 |
2018-12-11 |
9,724,598 |
Premium* |
|
Scpharmaceuticals Inc. |
SCPH |
10% Owner |
2019-04-11 |
0 |
2019-04-11 |
3,247,005 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-26 |
4 |
S |
$10.96 |
$7,424,790 |
I/I |
(670,000) |
8,032,014 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Former 10% Owner, See FN(5)(6) |
|
2014-09-29 |
4 |
S |
$10.96 |
$2,423,264 |
I/I |
(221,014) |
7,811,000 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
Former 10% Owner, See FN(5)(6) |
|
2014-09-30 |
4 |
S |
$10.02 |
$11,163,819 |
I/I |
(1,111,000) |
6,700,000 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-22 |
4 |
B |
$14.03 |
$75,883 |
I/I |
5,410 |
2,320,352 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-28 |
4 |
B |
$14.00 |
$2,088,800 |
I/I |
149,200 |
2,469,552 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-29 |
4 |
B |
$14.00 |
$1,330,000 |
I/I |
95,000 |
2,564,552 |
1.5 |
- |
|
WVE |
Wave Life Sciences Ltd. |
Director |
|
2015-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,172,060 |
5,213,651 |
0 |
- |
|
WVE |
Wave Life Sciences Ltd. |
Director |
|
2015-11-16 |
4 |
B |
$16.00 |
$30,000,000 |
I/I |
1,875,000 |
7,088,651 |
2.25 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-01-11 |
4 |
B |
$17.93 |
$74,479 |
I/I |
4,153 |
2,568,706 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-01-12 |
4 |
B |
$19.12 |
$113,585 |
I/I |
5,941 |
2,574,647 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-01-13 |
4 |
B |
$19.97 |
$110,674 |
I/I |
5,543 |
2,580,190 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-01-15 |
4 |
B |
$19.86 |
$35,743 |
I/I |
1,800 |
2,581,990 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-01-19 |
4 |
B |
$19.88 |
$83,480 |
I/I |
4,200 |
2,586,190 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-01-20 |
4 |
B |
$19.88 |
$35,849 |
I/I |
1,803 |
2,587,993 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-02-22 |
4 |
B |
$15.99 |
$180,958 |
I/I |
11,318 |
2,599,311 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-02-23 |
4 |
B |
$17.62 |
$500,512 |
I/I |
28,408 |
2,627,719 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-09-15 |
4 |
S |
$24.00 |
$8,459,290 |
I/I |
(351,950) |
2,275,769 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2016-09-16 |
4 |
S |
$24.50 |
$4,254,212 |
I/I |
(173,600) |
2,102,169 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
10% Owner |
|
2017-12-18 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,645,442 |
5,074,013 |
0 |
- |
|
THOR |
Synthorx, Inc. |
10% Owner |
|
2018-12-11 |
4 |
A |
$0.00 |
$0 |
I/I |
5,179,143 |
5,179,143 |
0 |
- |
|
THOR |
Synthorx, Inc. |
10% Owner |
|
2018-12-11 |
4 |
B |
$11.00 |
$50,000,005 |
I/I |
4,545,455 |
9,724,598 |
1.5 |
- |
|
SCPH |
Scpharmaceuticals Inc. |
10% Owner |
|
2019-04-11 |
4 |
B |
$2.70 |
$1,052,627 |
I/I |
389,862 |
3,247,005 |
1.5 |
- |
|
47 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|